Home

bomlanak oktatás Utat tör interferon kappa beta Húz Goneryl Finom

IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and  Therapeutic Potential of the Interferon Pathway in Systemic Lupus  Erythematosus and Other Autoimmune Diseases
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases

Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN)  signaling pathway | SpringerLink
Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway | SpringerLink

Immune response - IFN alpha/beta signaling pathway Pathway Map - PrimePCR |  Life Science | Bio-Rad
Immune response - IFN alpha/beta signaling pathway Pathway Map - PrimePCR | Life Science | Bio-Rad

The Overview of Interferon-CUSABIO
The Overview of Interferon-CUSABIO

Relevance of placental type I interferon beta regulation for pregnancy  success | Cellular & Molecular Immunology
Relevance of placental type I interferon beta regulation for pregnancy success | Cellular & Molecular Immunology

Frontiers | Importance of Type I and III Interferons at Respiratory and  Intestinal Barrier Surfaces
Frontiers | Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and  Heterogeneity across Diseases | PLOS ONE
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases | PLOS ONE

Early and delayed events in interferon signaling. The recognition of... |  Download Scientific Diagram
Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram

A clinical pilot study on the safety and efficacy of aerosol inhalation  treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 -  eClinicalMedicine
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine

Frontiers | Evasion of interferon-mediated immune response by arteriviruses
Frontiers | Evasion of interferon-mediated immune response by arteriviruses

IFN-κ suppresses the replication of influenza A viruses through the  IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling

An open-label, randomized trial of the combination of IFN-κ plus TFF2 with  standard care in the treatment of patients with moderate COVID-19 -  eClinicalMedicine
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine

The Overview of Interferon-CUSABIO
The Overview of Interferon-CUSABIO

IJMS | Free Full-Text | Emerging Roles of Type-I Interferons in  Neuroinflammation, Neurological Diseases, and Long-Haul COVID
IJMS | Free Full-Text | Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID

GeneCopoeia: IFN alpha signaling pathway
GeneCopoeia: IFN alpha signaling pathway

Decoding type I and III interferon signalling during viral infection |  Nature Microbiology
Decoding type I and III interferon signalling during viral infection | Nature Microbiology

Interferons: role in cancer therapy | Immunotherapy
Interferons: role in cancer therapy | Immunotherapy

Interferon target-gene expression and epigenomic signatures in health and  disease | Nature Immunology
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology

How cancer cells make and respond to interferon-I: Trends in Cancer
How cancer cells make and respond to interferon-I: Trends in Cancer

Interferons | Bio-Techne
Interferons | Bio-Techne

Cells | Free Full-Text | Signaling Pathways of Type I and Type III  Interferons and Targeted Therapies in Systemic Lupus Erythematosus
Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus

Interferons Research Area: R&D Systems
Interferons Research Area: R&D Systems

Frontiers | Shared and Unique Features of Human Interferon-Beta and  Interferon-Alpha Subtypes
Frontiers | Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes

IFN-κ suppresses the replication of influenza A viruses through the  IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling